Patient Derived Cancer Cell Lines in Identifying Molecular Changes in Patients With Previously Untreated Pancreatic Cancer Receiving Gemcitabine Hydrochloride-Based Chemotherapy

Clinical trial NCT02414100 · WITHDRAWN

Trial details

NCT number: NCT02414100
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Status: WITHDRAWN
Study type: OBSERVATIONAL

Pancreatic Ductal Adenocarcinoma Stage IA Pancreatic Cancer Stage IB Pancreatic Cancer Stage IIA Pancreatic Cancer Stage IIB Pancreatic Cancer Stage III Pancreatic Cancer Stage IV Pancreatic Cancer

Start date: 2013-12-12
Primary completion: 2016-12-15
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.